DYN
Dyne Therapeutics Inc · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website dyne-tx.com
- Employees(FY) 136
- ISIN US26818M1080
Performance
+6.67%
1W
+12.38%
1M
+20.82%
3M
+183.46%
6M
+108.12%
YTD
+103.98%
1Y
Profile
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts.
Investment Analysis Report: DYN
Overview
In this investment analysis report, we will delve into the financial statements of DYN, a company operating in the Health Technology sector within the Biotechnology industry. We will analyze the company's valuation, financial health, earnings and revenue growth, profitability, operating margin, operating ...
Technical Analysis of DYN 2024-05-10
Overview:
In analyzing the technical indicators for DYN over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and predictions for potential inve...
Recent News & Updates
- 2024-05-19 08:00
- 2024-05-18 20:00
- 2024-05-04 09:21
- 2024-05-04 05:31
- 2024-05-02 16:10
- 2024-05-02 11:52
DYN Stock Earnings: Dyne Therapeutics Misses EPS for Q1 2024(Investorplace)
- 2024-05-02 04:10
- 2024-04-30 07:32
- 2024-03-27 16:05
- 2024-03-27 08:30
- 2024-03-27 04:05
- 2024-03-26 20:30
- 2024-03-25 12:28
United Airlines, Dyne Therapeutics fall; Lucid Group, Century Aluminum rise, Monday, 3/25/2024(Associated Press Finance)
- 2024-03-25 07:30
Dyne Therapeutics Announces CEO Transition(GlobeNewswire)
- 2024-03-24 19:30
Dyne Therapeutics Announces CEO Transition(Globenewswire)
- 2024-03-13 07:30
Dyne Therapeutics to Present at Stifel 2024 Virtual CNS Days(GlobeNewswire)
- 2024-03-12 19:30
Dyne Therapeutics to Present at Stifel 2024 Virtual CNS Days(Globenewswire)
- 2024-03-07 13:19
- 2024-03-05 07:30
- 2024-03-04 21:53
DYN Stock Earnings: Dyne Therapeutics Misses EPS for Q4 2023(Investorplace)
- 2024-03-04 18:30
- 2024-03-02 00:00
- 2024-02-29 03:02
14 Stocks With Heavy Insider Buying In 2024(Insider Monkey)
- 2024-02-28 14:02
14 Stocks With Heavy Insider Buying In 2024(Insidermonkey)
- 2024-02-14 16:15
- 2024-02-14 03:15
- 2024-02-01 07:30
- 2024-01-31 18:30
- 2024-01-26 23:01
- 2024-01-22 22:14
7 Speculative Stocks to Double Your Money THIS Year(InvestorPlace)
Page 1 of 5
previousnext